Literature DB >> 1080353

The bleeding time as a test of hemostatic function.

A J Quick.   

Abstract

The vascular component of hemostatis is determined by the bleeding time as designed by Duke or by the Ivy modification, which is a combined bleeding time-tourniquet test. A prolonged bleeding time is observed: (1) in thrombopathic thrombocytopenia, which may be (a) hereditary or (b) acquired, as in the immune types or from depression of bone marrow, and (2) athrombocytopenically, as in von Willebrand's disease, Glanzmann's thrombasthenia, or from aspirin intolerance. The role of a specific bleeding time determinant in the plasma (labile bleeding time factor of Perkins) is discussed and its possible relation to platelets suggested.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080353     DOI: 10.1093/ajcp/64.1.87

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  An approach to the evaluation of hemostasis.

Authors:  S B Hunter; F S Royal; L D Green
Journal:  J Natl Med Assoc       Date:  1977-09       Impact factor: 1.798

2.  Novel identification of Factor XI deficiency in Indian Sahiwal (Bos indicus) cattle.

Authors:  Krishnendu Mondal; S Chakravarti; A K Ghosh; S Kumar; B Nayak; S Nandi; U Sarkar; Rajib Deb; A De; J Biswas
Journal:  Mol Biol Rep       Date:  2016-02-18       Impact factor: 2.316

3.  "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. II. Application in bleeding disorders.

Authors:  H Janzarik; D Heinrich; R H Bödeker; H G Lasch
Journal:  Blut       Date:  1988-09

4.  "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. I. Normal values, application in thrombocytopenic patients and evaluation of heparin and aspirin effects.

Authors:  H Janzarik; S Remy; S Morell; W Pabst
Journal:  Blut       Date:  1986-06

Review 5.  Platelet function tests: a comparative review.

Authors:  Rita Paniccia; Raffaella Priora; Agatina Alessandrello Liotta; Rosanna Abbate
Journal:  Vasc Health Risk Manag       Date:  2015-02-18

6.  Efficacy of Laropiprant in Minimizing Brain Injury Following Experimental Intracerebral Hemorrhage.

Authors:  Abdullah Shafique Ahmad; Monique Mendes; Damian Hernandez; Sylvain Doré
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

7.  A Human Vascular Injury-on-a-Chip Model of Hemostasis.

Authors:  Izmarie Poventud-Fuentes; Keon Woo Kwon; Jeongyun Seo; Maurizio Tomaiuolo; Timothy J Stalker; Lawrence F Brass; Dongeun Huh
Journal:  Small       Date:  2020-11-04       Impact factor: 13.281

8.  Glycoprotein VI in securing vascular integrity in inflamed vessels.

Authors:  Yacine Boulaftali; Marie-Anne Mawhin; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  Res Pract Thromb Haemost       Date:  2018-04-03

9.  Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects.

Authors:  Béatrice Hechler; Arnaud Dupuis; Pierre H Mangin; Christian Gachet
Journal:  Res Pract Thromb Haemost       Date:  2019-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.